Literature DB >> 16449336

Impaired cognitive function in women with congenital adrenal hyperplasia.

Trine H Johannsen1, Caroline P L Ripa, June M Reinisch, Marianne Schwartz, Erik L Mortensen, Katharina M Main.   

Abstract

CONTEXT: Congenital adrenal hyperplasia (CAH) is a disorder with a wide spectrum of severity.
OBJECTIVE: The objective of this study was to investigate cognitive function in CAH women.
DESIGN: This was a case-control study.
SETTING: This study was conducted at a tertiary center for pediatric endocrinology at the University Hospital of Copenhagen. PARTICIPANTS: Thirty-five Danish CAH women (age 17-51 yr) were included, and participation rate was 84%. Control women were recruited through the Danish Civil Registration System and matched on age and education. MAIN OUTCOME MEASURES: An abbreviated form of the Wechsler Adult Intelligence Scale was used, i.e. full-scale intelligence quotient (IQ; five of 11 subtests), which included three of six verbal IQ subtests and two of five performance IQ subtests.
RESULTS: A significantly lower IQ was found in CAH patients compared with controls with respect to mean full-scale IQ (84.5 vs. 99.1; P < 0.001), mean verbal IQ (86.6 vs. 97.3; P < 0.001), and mean performance IQ (85.7 vs. 101.3; P < 0.001). The salt-wasting CAH group had lower IQ scores than the simple-virilizing CAH group, which reached significance for mean total IQ (81.2 vs. 92.8, P = 0.04) and mean verbal IQ (84.7 vs. 95.5, P = 0.05), and additionally, lower scores than the late-onset CAH group, which reached significance for performance IQ (mean 81.5 vs. 96.2, P = 0.02).
CONCLUSIONS: Impaired cognitive function was observed in patients with CAH, especially in salt-wasting CAH. These intriguing findings may reflect adverse effects of hyponatremic episodes, suboptimal postnatal hormone replacement therapy or prenatal adrenal androgen excess, and the potential psychosocial consequences of the disorder.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16449336     DOI: 10.1210/jc.2005-1959

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  17 in total

Review 1.  Adrenal steroidogenesis and congenital adrenal hyperplasia.

Authors:  Adina F Turcu; Richard J Auchus
Journal:  Endocrinol Metab Clin North Am       Date:  2015-06       Impact factor: 4.741

2.  Cognitive outcome of offspring from dexamethasone-treated pregnancies at risk for congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

Authors:  Heino F L Meyer-Bahlburg; Curtis Dolezal; Rita Haggerty; Michael Silverman; Maria I New
Journal:  Eur J Endocrinol       Date:  2012-05-01       Impact factor: 6.664

3.  Amygdala function in adolescents with congenital adrenal hyperplasia: a model for the study of early steroid abnormalities.

Authors:  Monique Ernst; Françoise S Maheu; Elizabeth Schroth; Julie Hardin; Liza Green Golan; Jennifer Cameron; Rachel Allen; Stuart Holzer; Eric Nelson; Daniel S Pine; Deborah P Merke
Journal:  Neuropsychologia       Date:  2007-02-03       Impact factor: 3.139

4.  Long-Term Gynecological Outcomes in Women with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency.

Authors:  T H Johannsen; C P L Ripa; E Carlsen; J Starup; O H Nielsen; M Schwartz; K T Drzewiecki; E L Mortensen; K M Main
Journal:  Int J Pediatr Endocrinol       Date:  2010-10-20

5.  Steroid abnormalities and the developing brain: declarative memory for emotionally arousing and neutral material in children with congenital adrenal hyperplasia.

Authors:  Françoise S Maheu; Deborah P Merke; Elizabeth A Schroth; Margaret F Keil; Julie Hardin; Kaitlin Poeth; Daniel S Pine; Monique Ernst
Journal:  Psychoneuroendocrinology       Date:  2007-12-26       Impact factor: 4.905

6.  Cognitive function in children with classic congenital adrenal hyperplasia.

Authors:  Sherifa Ahmed Hamed; Kotb Abbass Metwalley; Hekma Saad Farghaly
Journal:  Eur J Pediatr       Date:  2018-08-07       Impact factor: 3.183

7.  Reduced short term memory in congenital adrenal hyperplasia (CAH) and its relationship to spatial and quantitative performance.

Authors:  Marcia L Collaer; Peter C Hindmarsh; Vickie Pasterski; Briony A Fane; Melissa Hines
Journal:  Psychoneuroendocrinology       Date:  2015-12-01       Impact factor: 4.905

8.  Approach to the adult with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

Authors:  Deborah P Merke
Journal:  J Clin Endocrinol Metab       Date:  2008-03       Impact factor: 5.958

9.  No Evidence for Enhancement of Spatial Ability with Elevated Prenatal Androgen Exposure in Congenital Adrenal Hyperplasia: A Meta-Analysis.

Authors:  Marcia L Collaer; Melissa Hines
Journal:  Arch Sex Behav       Date:  2020-02-12

Review 10.  Treatment and health outcomes in adults with congenital adrenal hyperplasia.

Authors:  Thang S Han; Brian R Walker; Wiebke Arlt; Richard J Ross
Journal:  Nat Rev Endocrinol       Date:  2013-12-17       Impact factor: 43.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.